Amgen Head-To-Head R&D Strategy Speaks To Growing Importance Of Payers

Amgen's strategy of conducting head-to-head trials of its products against current standards of care pre-approval indicates the firm is focusing on effectively positioning products in an increasingly competitive, Medicare-oriented reimbursement environment